FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
|Videos|November 15, 2022
A new possible solution to vaginal odor?
Author(s)Morgan Ebert
Alyssa Dweck, MD, discusses some recent positive data presented at the 2022 NAMS meeting regarding Clairvee (Bonafide Health) as a potential treatment for vaginal odor.
Advertisement
Alyssa Dweck, MD, gynecologist and chief medical officer of Bonafide Health, discusses some recent positive data presented at the 2022 NAMS meeting regarding Clairvee (Bonafide Health) as a potential treatment for vaginal odor.
Advertisement
Related to this article
Take a look back at some of the top FDA and pipeline news in women's health from August 2026.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Off-label testosterone dosing, access, and lab monitoring in the US
2
Survey: 51% of US-women report negative healthcare experiences
3
Kevin Ault, MD, on coordinating RSV prevention across maternal and pediatric care
4
FDA holding public meeting on testosterone use in menopausal women
5